Articles from City of Hope

Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center in Los Angeles ranked among the nation’s top 5 cancer centers by U.S. News & World Report, and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient’s likely response to chimeric antigen receptor (CAR) T cell therapy before starting the treatment, according to study results published today in Nature Medicine.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, has opened a phase 1 trial seeking to one day transform rectal cancer from a mostly radiation-resistant disease to one that can be cured using radiation and chemotherapy.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a phase 1/2 clinical trial investigating an osteoporosis medication as a way to improve beta cell health in people with early type 1 diabetes.

A phase 1 clinical trial led by City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, has demonstrated the safety and early efficacy of targeted chemotherapy using PIPAC combined with systemic chemotherapy for patients with colorectal and appendiceal cancer that has spread to the peritoneum of the abdominal cavity. This data will be presented at a March 18 press briefing spotlighting some of the most consequential research to be shared at this year’s Society of Surgical Oncology Annual Meeting (SSO).

The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) is creating transformative new programs in a groundbreaking search for a cure for pancreatic cancer. Fueled by the extraordinary $150 million gift announced in September 2024 from entrepreneurs and philanthropists, A. Emmet Stephenson Jr. and Tessa Stephenson Brand, this is an innovative, multifaceted approach to accelerate the extinction of one of the deadliest cancers by recognizing visionary scientists and catalyzing game-changing research. The Stephenson family selected City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, as a key partner to facilitate this lifesaving work.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, marks World Cancer Day by announcing bold solutions to address the most urgent cancer challenges, including groundbreaking advancements in microbiome research to improve cancer survival, more focus on cancers disproportionately impacting women and minorities, and wider access to advanced cancer care.

A team of international researchers led by scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center in Los Angeles ranked among the nation’s top 5 cancer centers by U.S. News & World Report, have demonstrated a way to boost thymic function after damage in preclinical studies. The team’s study results, published today in the journal Immunity, outline their discovery of a specific type of regulatory T cell that can home back into the thymus and repair the organ when it's damaged.

This month, the Illinois House of Representatives unanimously passed the Illinois Cancer Patients Bill of Rights, a resolution and call-to-action which states that all Illinois residents with cancer diagnoses should be able to access new and emerging treatments, receive care at advanced care centers, and be supported throughout their entire care journey – regardless of their means or background. The resolution was championed by City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center in Los Angeles ranked among the nation’s top 5 cancer centers by U.S. News & World Report and with a leading cancer center in Zion, Ill.

Physician-researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States with its National Medical Center named Top 5 in the nation for cancer by U.S. News & World Report, have developed a way to add features to T cells to help them overcome mechanisms of chimeric antigen receptor (CAR) T cell therapy resistance. Their new system is outlined in a paper published today in Nature Biomedical Engineering.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report and a leading research center for diabetes, will celebrate its 51st float in the 2025 Rose Parade.

Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have collared a tricky culprit that helps cancer cells evade CAR T cell therapy.

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose Los Angeles comprehensive cancer center is ranked among the nation’s top 5 cancer centers by U.S. News & World Report, presented new study results on treatment options, side effect prevention and risk prediction for blood cancer patients at this year’s ASH conference in San Diego, California, held Dec. 7 to 10.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose Los Angeles comprehensive cancer center is ranked among the nation’s top five cancer centers by U.S. News & World Report, reported on promising early results from a phase 1b/2 clinical trial using epcoritamab, a new bispecific T cell engager, for patients with relapsed or refractory CLL.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, announced today that its CEO, Robert Stone, has been named to Modern Healthcare’s prestigious list of the 100 Most Influential People in Health Care.

Scientists and physicians with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., whose Los Angeles comprehensive cancer center is ranked among the nation’s top 5 cancer centers by U.S. News & World Report, presented new research on high-fiber dietary interventions for patients at risk for graft-versus-host-disease (GVHD) and myeloma at a press briefing today at this year’s ASH conference, taking place Dec. 7 to 10 in San Diego.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, announced today that its doctors and scientists will take part in 100 oral and poster presentations, scientific symposia/workshops, education programs and other events at ASH annual meeting from Dec. 7 to 10 in San Diego.

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, now understand why taking an investigational white button mushroom supplement shows promise in slowing and even preventing prostate cancer from spreading among men who joined a phase 2 clinical trial studying “food as medicine.” Looking at preclinical and preliminary human data, the City of Hope scientists found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells (MDSCs), which has been linked to cancer development and spread.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, hosted two events at City of Hope Phoenix to recognize cancer survivors, patients and caregivers and to bring together members of the community for a walk that benefits cancer research that aims to end cancer for all. Actor and cancer survivor Colin Egglesfield attended both events to support other cancer survivors, patients and their loved ones, share his story and help City of Hope spread its message of hope for those impacted by this devastating disease.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report, announced today that Loretta Erhunmwunsee, M.D., City of Hope thoracic surgeon, has been named a Cancer Moonshot Scholar by the Biden Cancer Moonshot for her research linking social and environmental factors to the development of lung cancer in African Americans.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, honored the growing community of cancer survivors treated at City of Hope Atlanta and their inspiring journeys to recovery at the annual Celebrate Life® event.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World report, honored Jay Marciano, chairman and CEO of AEG Presents, at tonight’s Music, Film and Entertainment Industry Spirit of Life® Gala. The gala is part of the industry’s annual philanthropic campaign, which has raised more than $7.5 million to-date to advance City of Hope’s mission of making hope a reality for all touched by cancer and diabetes. With the evening’s proceeds benefiting childhood, adolescent and young adult survivorship programs, fundraising will continue through the end of 2024.

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation’s top 5 cancer centers by U.S. News & World Report and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, will present new data on integrative oncology research and clinical trials at the 21st International Conference of the Society for Integrative Oncology taking place Oct. 25 to 27.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, honored the growing number of cancer survivors who have received care at City of Hope Chicago and their powerful journeys to becoming cancer free at its annual Celebrate Life® event.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, is part of today’s press conference program at the American Society for Radiation Oncology (ASTRO) Annual Meeting, where a renowned City of Hope radiation oncologist will present phase 3 clinical trial data showing that people with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time. The results suggest that the timing of when immunotherapy is given plays a key role in its ability to extend survival.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., has received a $20 million gift from philanthropists Norman and Melinda Payson to create a pancreas center that will advance groundbreaking research and treatments for pancreatic cancer and diabetes.

A team of researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., and The University of Texas M.D. Anderson Cancer Center, have reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic lymphoma, a rare and slow-growing type of blood cancer, according to a study published recently in Nature Communications.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, has received a historic $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to immediately fund pancreatic cancer research.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., today announced that Simon Nazarian will join the organization as its new executive vice president and chief digital and technology officer. In this role, Nazarian will lead City of Hope’s overall technology strategy, transforming and expanding technology innovation through digital, AI and advanced analytics initiatives. Nazarian will report to Robert Stone, City of Hope’s chief executive officer.

City of Hope Orange County, part of one of the largest and most advanced cancer research and treatment organizations in the United States, announced today that world-renowned colorectal surgeon Alessio Pigazzi, M.D., Ph.D., has joined the organization as clinical professor of surgery, executive medical director of colorectal surgery and vice chair of clinical network affairs for the Department of Surgery.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, announced today that its Music, Film and Entertainment Industry (MFEI) volunteer and fundraising group’s Spirit of Life® Gala will include a headlining performance by Elton John!

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, announced today that multiple Grammy Award-winning singer-songwriter Christina Aguilera will perform at its “Promises of Hope” fundraiser.

John D. Carpten, Ph.D., chief scientific officer at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., has been named a top diversity leader in U.S. health care by Modern Healthcare magazine. Dr. Carpten, a renowned genome scientist, is recognized for his leadership in cancer research and pioneering work in identifying genomic factors contributing to cancer disparities among individuals from underrepresented groups, including groundbreaking research on prostate cancer in African Americans.

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Institute for Follicular Lymphoma Innovation (IFLI) today announced a $2 million, three-year collaboration to study spontaneous remission in follicular lymphoma, the most common, slow-growing non-Hodgkin's lymphoma.

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, has been recognized as having one of the nation’s top 5 hospitals for cancer care, according to U.S. News & World Report’s 2024-25 rankings. City of Hope is the only California-based cancer institution ranked in the top 5. The recognition marks the latest milestone for City of Hope as it enhances its ability to make a meaningful impact in the lives of patients, families and communities nationwide.

In preclinical studies, a team of researchers from City of Hope® in Los Angeles and Mount Sinai Health System in New York reports new findings on a therapeutic combination that regenerated human insulin-producing beta cells, providing a possible new treatment for diabetes. The findings were published today in Science Translational Medicine.

Physician scientists from City of Hope, one of the largest cancer research and treatment organizations in the United States, found that people with metastatic kidney cancer who orally took a live biotherapeutic product called CBM588 while in treatment with immunotherapy and enzymatic tyrosine kinase inhibitors experienced improved health outcomes. The phase 1 trial was published today in Nature Medicine.

Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, presented novel study results at the 84th Scientific Sessions of ADA held June 21 to 24 in Orlando, Florida.

City of Hope®, one of the largest cancer research and treatment organizations in the U.S., and Charles R. Drew University of Medicine and Science (CDU), the only Historically Black Graduate Institution west of the Mississippi River and one of only four Historically Black Medical Schools, announced the launch of a new partnership to educate a more diverse workforce in specialized medicine through internships, curriculum, training, mentorships, joint research projects and more.

Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, showed that patients with advanced prostate cancer had minimal side effects with the cellular immunotherapy and had promising therapeutic activity, according to a study published today in Nature Medicine.

A new study guided by a renowned surgeon at City of Hope®, one of the largest cancer research and treatment organizations in the United States, demonstrates that robotic liver surgery can be a safe, outpatient procedure. In fact, 8% of the patients sampled in the analysis were discharged to go home on the same day.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, today announced that effective June 10, Angelique L. Richard, Ph.D., R.N., will be chief operating officer of City of Hope National Medical Center, City of Hope Los Angeles, City of Hope Orange County and City of Hope’s Southern California clinical network.

World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new data and offer expert perspectives on leading-edge cancer research and treatments in development at the 2024 ASCO Annual Meeting, which will take place in Chicago from May 31 to June 4. Highlights include the following:

In a paper published today in Science Translational Medicine, researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes (T1D) patients.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its Duarte, California, campus that will further expand its scientific capabilities.

City of Hope, one of the largest cancer research and treatment organizations in the United States, has once again been recognized by Fair360 (formerly DiversityInc) as one of the “Top Hospitals and Health Systems” in the country for diversity, equity and inclusion (DEI), ranking second on a list of 20 reputable health care organizations for the second year in a row. As the top National Cancer Institute-designated comprehensive cancer center, City of Hope is holding strong in the specialty ranking’s top 10 for the fourth consecutive year.

World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new findings and offer expert perspectives on leading-edge cancer research and treatment development at the ASCO Annual Meeting 2024, which will take place in Chicago from May 31 to June 4.

At nine years old, Tammy Wang has already survived cancer twice. She was just four years old when she was diagnosed with leukemia and received chemotherapy for 2.5 years at City of Hope Children’s Cancer Center. Just six months after chemotherapy ended, Tammy’s leukemia returned. Tammy, who is an only child, would need a transplant to beat the cancer again and put it into long-lasting remission.

Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present more than 70 abstracts and sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment options as well as share their expertise on molecular profiling and the microbiome at the AACR Annual Meeting, which started April 5 and ends April 10 in San Diego.

Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new findings at the AACR Annual Meeting, which will take place April 5 to 10 in San Diego.

A pioneering Phase 1 CAR T cell therapy trial for the treatment of glioblastoma at City of Hope, one of the largest cancer treatment and research organizations in the United States, demonstrates promising clinical activity against incurable brain tumors, according to research published today in Nature Medicine.

City of Hope, one of the largest cancer research and treatment organizations in the United States, is taking leading-edge clinical screening and care into Southern California communities and beyond with the launch of their new mobile cancer prevention and screening program. The program, the first in the U.S. to provide this level of mobile comprehensive cancer prevention and screening services, marks an important advancement in City of Hope’s long-standing mission to bridge health equity gaps and address community health needs.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person to be cured of a blood cancer and then achieve remission for HIV after receiving a blood stem cell transplant from a donor with a rare genetic mutation. Research published in NEJM today demonstrates that older adults with blood cancers who receive reduced intensity chemotherapy before a stem cell transplant with donor cells that are resistant to HIV may be cured of HIV infection.

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, and Translational Genomics Research Institute (TGen), a precision medicine research organization that is part of City of Hope, have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws. The study was published today in the journal Science Translational Medicine.

City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Kristin Higgins, M.D., as the chief clinical officer at City of Hope Cancer Center Atlanta. She joins City of Hope from Emory Healthcare, where she served as a physician, radiation oncologist and as the medical director of radiation oncology, leader of Winship Cancer Institute’s lung program, and member of the Discovery and Developmental Therapeutics Research Program.

Leaders at City of Hope, one of the largest cancer research and treatment organizations in the United States, forecast that in 2024 more people will benefit from cancer breakthroughs, including research that unlocks the biology behind cancer disparities, wider access to CAR T cell therapy and rapid whole genome sequencing.

According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers with City of Hope®, one of the largest cancer treatment and research organizations in the United States, have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer.

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure. The findings published in The Lancet Oncology show that the blood vessel relaxing medication carvedilol is safe for childhood cancer survivors to take and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

Eight cancer survivors and their doctors from throughout City of Hope’s national cancer system will celebrate the joy and music of life during the 135th Rose Parade on Jan. 1 by riding on City of Hope’s float.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today that 23% of patients with relapsed or treatment-resistant KMT2Ar AML, ALL and mixed phenotype leukemia who took revumenib in the AUGMENT-101 multicenter clinical trial had a complete remission (CR) — the cancer went into remission with complete recovery of peripheral blood counts — or a CRh — the cancer went into remission and there was partial recovery of peripheral blood counts. The data was presented as a late-breaking abstract at ASH and in a press briefing. Revumenib is a highly selective inhibitor of the menin-KMT2A binding interaction that is being developed by Syndax Pharmaceuticals.

Physicians and scientists with City of Hope, one of the largest cancer research and treatment organizations in the United States, presented data on potential new treatment options for blood cancers at this year’s American Society of Hematology (ASH) conference in San Diego, California, Dec. 9 to 12.

City of Hope, one of the largest cancer research and treatment organizations in the United States, will present innovative research at this year’s San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 5 to 9 in San Antonio, Texas.

City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope. He joins City of Hope from Mayo Clinic, where he served as chair of the Division of Hematology and Medical Oncology in the Department of Internal Medicine at Mayo Clinic in Arizona and director of Mayo Clinic Comprehensive Cancer Center in Arizona.

City of Hope®, one of the largest cancer research and treatment organizations in the United States, honored Lyor Cohen, global head of Music at YouTube and Google, tonight at its Music, Film and Entertainment Industry (MFEI) fundraising group’s Spirit of Life® Gala. The annual event featured a special performance from LL Cool J and DJ Jazzy Jeff, plus a curated “DJ Cassidy’s Pass The Mic Live!” segment with – in order of appearance – Slick Rick, Kurtis Blow, Big Daddy Kane, MC Serch, Nice ‘N Smooth, EPMD, Redman, Onyx, Warren G, Domino, Musiq Soulchild, Dru Hill, Ja Rule, T.I., Swizz Beatz and Public Enemy.

Scientists with City of Hope®, one of the largest cancer research and treatment organizations in the United States, and the Translational Genomics Research Institute (TGen), part of City of Hope, may have discovered one of the causes for a type of leukemia to develop into a more aggressive form, according to recent research published in Nature Communications.

John D. Carpten, Ph.D., chief scientific officer at City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, was presented with one of the highest honors in health and medicine today when he was elected to the National Academy of Medicine (NAM).

City of Hope, one of the largest cancer research and treatment organizations in the United States, is opening a multicenter clinical trial to evaluate the efficacy of robotic-assisted, single-incision mastectomies. The minimally invasive procedure, which preserves the nipple and leaves only a small hidden scar on the side of the body, could potentially lead to significant improvements for breast surgery.

A new study by researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, reveals that people with neuroendocrine cancer overwhelmingly prioritize quality of life over living longer. The study, entitled “Patient-Defined Goals and Preferences Among Adults With Advanced Neuroendocrine Tumors,” was published today in the Journal of the National Comprehensive Cancer Network.

A study led by City of Hope, one of the largest cancer research and treatment organizations in the United States, found that Black women with Stage 1 or 2 breast cancer were almost three times more likely than white women to have tumor shrinkage from hormone therapy delivered prior to surgery, yet Black women were more likely than their white counterparts to have worse outcomes when this type of endocrine therapy before surgery was used at a later stage of disease. The results will be presented at the virtual 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Sept. 16 to 19, 2022.

City of Hope, one of the largest cancer research and treatment organizations in the United States, has received a $25 million gift from Julia and George Argyros, visionary philanthropists and longtime City of Hope supporters. The transformational gift, announced by Argyros Family Foundation president Julia A. Argyros during the Sept. 10 Hope Gala, advances City of Hope’s mission to deliver world-renowned research, treatment and cancer cures to Orange County. The gala raised $2.3 million, in addition to the announcement of the Argyros family’s transformational $25 million gift to City of Hope Orange County.

The Translational Genomics Research Institute (TGen), part of City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced a partnership with actress, singer-songwriter and advocate Lynda Carter Altman to accelerate diagnostics and treatments, including precision medicine approaches, for a deadly and difficult-to-treat form of blood cancer.

City of Hope, one of the largest cancer research and treatment organizations in the United States, is sending the iconic Great Park Balloon in Irvine, California, into the sky with a message of hope for ending the disease that affects 1 in 3 Americans in their lifetime. The balloon’s inaugural flight will take place today as the first patients walk through the doors of City of Hope Orange County Lennar Foundation Cancer Center four miles away.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today that Grammy-nominated recording artist Nick Jonas will perform at the upcoming “Hope Gala” at Segerstrom Center for the Arts in Costa Mesa, California. City of Hope Orange County’s inaugural “Hope Gala” will bring together leaders and luminaries from the community to honor visionary philanthropist Julia A. Argyros, a longtime supporter of City of Hope.

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, may have developed a novel blood test that can be used to detect early-onset colorectal cancer, which has been on the rise in younger adults in recent years.

City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that it has been approved for nearly $7 million from the Patient-Centered Outcomes Research Institute (PCORI) to study how physical activity affects older adults undergoing lung cancer surgery.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today that a 66-year-old man who was diagnosed with HIV in 1988 has been in remission of the virus for over 17 months after stopping antiretroviral therapy (ART) for the disease following a stem cell transplant from an unrelated donor for leukemia, according to research presented today at the AIDS 2022 press conference by Jana K. Dickter, M.D., City of Hope associate clinical professor in the Division of Infectious Diseases. He received the transplant nearly 3 1/2 years ago at City of Hope.